CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX)

Market Closed
26 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
2. 22
-0.1
-4.3103%
After Hours
$
2. 55
+0.33 +14.8649%
505.53M Market Cap
- P/E Ratio
- Div Yield
501,184 Volume
-0.06 Eps
$ 2.32
Previous Close
Add Transaction
Day Range
2.19 2.37
Year Range
2.19 8.21
Want to track CTMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CytomX Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Amir Har-El
Amir Har-El Savvy Advisors, Inc.
17,700 $66,375 $39,028.5 -$27,346.5 -41.2%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
3.46M $16.25M $7.76M -$8.49M -52.23%
Darin Sadow
Darin Sadow Freestone Grove Partners LP
18,972 $71,145 $42,592.14 -$28,552.86 -40.13%
BRIANNE SHERGILL
BRIANNE SHERGILL Exome Asset Management LLC
460,067 $1.47M $1.05M -$420,961.36 -28.68%
Joe Miller
Joe Miller Miller Financial Services LLC
87,000 $170,570.9 $194,445 $23,874.1 14%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
52,499 $196,871 $117,072.77 -$79,798.23 -40.53%
Richard Harris
Richard Harris Aspire Growth Partners LLC
102,254 $97,430.21 $227,515.15 $130,084.94 133.52%
William Jones
William Jones TEMA ETFs LLC
228,987 $1.07M $527,815.03 -$547,016.47 -50.89%
GF Fund Management Co. Ltd.
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
4,302 $18,265.92 $10,077.87 -$8,188.05 -44.83%
John Ciaran Burns
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
50,529 $214,810.87 $113,437.6 -$101,373.27 -47.19%